Latest News

Neovasc Announces First Patient Enrollment in COSIRA-II Trial

COSIRA-II Trial Designed to Study the Neovasc Reducer(TM) for Patients with Refractory Angina VANCOUVER and MINNEAPOLIS – (NewMediaWire) – January 05, 2022 – Neovasc Inc. (NASDAQ: ...

ABVC BioPharma Selects Additional Vitargus Phase II Study Sites

Thailand Sites Join Australian Sites Confirmed to Participate in the Study Fremont, CA – (NewMediaWire) – January 05, 2022 – ABVC BioPharma, Inc. (NASDAQ: ABVC), ...

CES 2022: Minim First to Offer In-App Chat Support; Announces Two New Motorola Mesh WiFi 6 Systems

Minim introduces new motosync app features and an expanded mesh WiFi portfolio, including a first-of-its-kind, ultra-high-speed wideband WiFi 6E mesh system Manchester, NH – (NewMediaWire) ...

Study in mice finds erectile dysfunction medication worsened abdominal aortic aneurysms

Research Highlights: A laboratory study in mice with a bulging or weakening in the main artery supplying blood to the abdomen and legs – ...